Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p.
Blood
; 119(4): 940-8, 2012 Jan 26.
Article
in En
| MEDLINE
| ID: mdl-22160383
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyrazines
/
Boronic Acids
/
Stem Cell Transplantation
/
Induction Chemotherapy
/
Maintenance Chemotherapy
/
Multiple Myeloma
/
Antineoplastic Agents
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Blood
Year:
2012
Type:
Article
Affiliation country:
Germany